Farxiga granted FDA Priority Review for patients with heart failure with reduced ejection fraction

 

Farxiga granted FDA Priority Review for patients with heart failure with reduced ejection fraction

By following the science to understand more clearly the underlying links between the heart, kidneys and pancreas, AstraZeneca is investing in a portfolio of medicines to protect organs and improve …

More Farxiga granted FDA Priority Review for patients with heart failure with reduced ejection fraction Videos

Leave a Reply